The Sensex closed higher by 170 points at 26,128 and the Nifty rose 59 points to end at 7,943.
'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.
There is a 'very low risk' of further international spread of Zika virus as result of the Olympic Games to be held in Brazil, the heart of the current outbreak linked to birth defects, World Health Organization (WHO) experts said on Tuesday.
The 30-share Sensex ended down by 59 points at 27,027 and the 50-share Nifty slipped 7 points at 8,087.
A group of high-powered individuals led by Anand Mahindra have come together to set up Krea university. The campus is expected to be ready by 2019 and the first batch of 100 to 125 students will commence classes in August next year.
The 30-share Sensex and the 50-share Nifty ended flat at the mark of 29,008 and 8,767 respectively.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
Having invested close to $15 billion in Indonesia, Indian firms have lined up further $15-16 billion investments.
How much do you know Russian billionaire Yuri Milner, who has invested $ 100 million in a project to find extra-terrestrial life?
Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
The 30-share Sensex ended 79 points lower at 26,909 and the 50-share Nifty closed 25 points lower at 8,102.
Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations
The 36th India Day Parade ran through about 13 streets in Madison avenue in Manhattan.
Tata Motors, ONGC, HDFC and TCS were the top gainers.
'We are at a time and position that we do not need higher number of visas.'
In an online chat with readers overseas education consultant NNS Chandra addressed queries related to international admissions.
The Bangalore-headquartered firm had posted a net profit of Rs 1,623.3 crore (Rs 16.23 billion) in the year-ago period, it said in a BSE filing.
The outgoing chairman believed in building for the future; for his successor, the challenge will be to maintain the momentum, says Ishita Ayan Dutt.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
BSE Midcap index outperformed the benchmark indices to end with 0.4% gains.
When it comes to key hands-on management positions, India Inc is still largely run by men.
Custodian banks are selling dollars for their foreign fund clients.
Indians are welcome to study and work in Great Britain, says UK's Minister for Science and Universities Jo Johnson.
Markets rebound with financials leading the gains on hopes of a peaceful solution to the turmoil in Ukraine
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
From Lalit K Jha Washington, May 15 (PTI) Alleging that recent trade policies of India are jeopardising its trade ties with the US, a Washington-based think tank has recommended the Congress to suspend trade benefits for New Delhi. "To be clear, a strong, growing, and collaborative trade relationshi ...
Today Aashirvaad, ITC says, has 75 per cent of the market.
After taking over scam-hit Satyam, Techn Mahindra has made many structural changes in the latter to turn it around.
As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
Amid subdued demand for traditional information technology (IT) services offerings, Indian IT services players are betting on big data, as this is high on clients' agenda.
US stocks rose more than 1% on Tuesday, with the S&P 500 coming less than 2% below its record peak set last month.
Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer , casting serious doubt on the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals group.
Markets recovered in late trades, amid firm European cues, led by rebound in financials and gains in IT shares.
New strategy for Infosys by October, says Nandan Nilekani. New chairman's other priorities: Hiring CEO, reviewing Panaya probe reports.
The government may claim planted trees compensate for forests lost, but that does not mean complex flora and fauna destroyed have been restored, points out Himadri Ghosh.
The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.
The company's net profit went up 27% in December quarter, sequentially better than peers; core IT services up 33%..
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances